Since 1949, the AHA has invested $4.9 billion in cardiovascular and cerebrovascular disease research.
About AHA Research
Funding research is a cornerstone of the American Heart Association’s lifesaving mission -- a pillar upon which the AHA was founded and a key to our future. The AHA is the largest not-for-profit funding source for cardiovascular and cerebrovascular disease research next to the federal government. New knowledge resulting from AHA funding benefits millions of lives in every corner of the U.S. and around the world:
- Translation into medical advancements
- Updated guidelines for healthcare providers to most effectively treat patients and improve people's well-being
- Building careers in science and research
Our bold research vision is guided by 12 Essential Elements to ensure AHA is at the forefront of global changes, emphasizes collaborative and team research, accelerates discovery, and drives groundbreaking research outcomes.
The AHA Research Committee and Subcommittees are composed of science and medicine volunteers. They establish and direct the organization's research policies and programs.
Health Equity Research Network (HERN) on Disparities in Maternal-Infant Health Outcomes
The American Heart Association (AHA) has committed $20 million to establish this Health Equity Research Network -- an opportunity to significantly advance our understanding of the factors underlying the disproportionate impact of maternal mortality and morbidity on Black women, Native American women, and those living in rural areas. Because heart and vascular issues account for about half of these deaths, the AHA is uniquely positioned to address this critical issue. Awardees will be announced before July 1st.
A team of researchers, led by Deepak Srivastava and including AHA-funded Barbara Gonzalez Teran, developed a novel method for identifying genetic variants that are likely to play important roles in congenital heart disease, opening up opportunities to accelerate research into this serious condition. The study was funded in part by an AHA/CHF Congenital Heart Defect Research Award and was published in the journal Cell.
The American Heart Association is working to ensure optimal care for patients with cardiovascular disease who contract coronavirus (COVID-19). Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with COVID-19. Helpful resources for health systems, clinics, care providers, patients and the public can be found on the COVID-19 Content: An AHA Compendium.
AHA Awardees: Apply for a Precision Medicine Platform workspace to perform data analyses
The workspace will provide up to $50,000 in AWS credits per year during an AHA award. Register for a free account on the AHA Precision Medicine Platform. Learn more about the platform (video).
Follow us on Twitter @AHA_Research
The official Twitter account for the Research of the American Heart Association
2022 AHA Holidays
AHA offices will be closed on the following days. Inquiries will be answered as quickly as possible upon reopening.
|Jan. 17||Sept. 5|
|May 27 - 30||Nov. 24 & 25|
|July 1 & 5||Dec. 26 - Jan. 2|